Morgan Stanley Keeps Their Hold Rating on Ascendis Pharma (ASND)
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of ...
Axsome Therapeutics: Strong Buy Recommendation Driven by Promising Pipeline and Market Expansion
Needham analyst Ami Fadia maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of $133.00.Don't ...